5
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The impact of health literacy on COVID-19 immunization

      research-article
      , , ,
      Human Vaccines & Immunotherapeutics
      Taylor & Francis
      COVID-19 vaccines, health literacy, vaccine hesitancy

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          The COVID-19 pandemic can be controlled by vaccination in addition to public health measures. This study investigate the impact of Health Literacy (HL) on vaccination and COVID-19. 334 patients and patient’s relatives aged 18 to 65 years who were followed up at the Infectious Diseases Clinic between March and July 2022 for reasons other than COVID-19 disease were included in the study. The COVID-19 vaccination status of each participant was queried and the preferred vaccination was recorded on the case form. The mean age was 40.9 years, and 52.4% (n:175) of participants were women. It was found that 82.3% (n:275) of participants had received at least one dose of the vaccine COVID-19. It was found that 17.6% of participants had not been COVID-19 vaccinated. It was found that 60.7% (n:203) of participants received ≥ 2 doses of the mRNA-based viral vaccine. Vaccination rates were found to be significantly lower in patients with ‘inadequate’ HL ( p = .047). In addition, the vaccination rate was lower in people aged 39 years and younger and in the presence of one or more chronic diseases. When chronic diseases are present, COVID-19 becomes more severe. On the other hand, the disease shows a moderate clinical picture and plays a significant role in transmission to risk groups in the young population, where vaccination rates are low. This situation in the context of COVID-19 demonstrates once again the importance of informing at-risk groups and the healthy young population about vaccine-preventable diseases.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases

          Despite major advances in vaccination over the past century, resurgence of vaccine-preventable illnesses has led the World Health Organization to identify vaccine hesitancy as a major threat to global health. Vaccine hesitancy may be fueled by health information obtained from a variety of sources, including new media such as the Internet and social media platforms. As access to technology has improved, social media has attained global penetrance. In contrast to traditional media, social media allow individuals to rapidly create and share content globally without editorial oversight. Users may self-select content streams, contributing to ideological isolation. As such, there are considerable public health concerns raised by anti-vaccination messaging on such platforms and the consequent potential for downstream vaccine hesitancy, including the compromise of public confidence in future vaccine development for novel pathogens, such as SARS-CoV-2 for the prevention of COVID-19. In this review, we discuss the current position of social media platforms in propagating vaccine hesitancy and explore next steps in how social media may be used to improve health literacy and foster public trust in vaccination.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Aging in COVID-19: Vulnerability, immunity and intervention

            The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic was first reported in Wuhan, China in December 2019, moved across the globe at an unprecedented speed, and has caused a profound and yet still unfolding health and socioeconomic impacts. SARS-CoV-2, a β-coronavirus, is a highly contagious respiratory pathogen that causes a disease that has been termed the 2019 coronavirus disease (COVID-19). Clinical experience thus far indicates that COVID-19 is highly heterogeneous, ranging from being asymptomatic and mild to severe and causing death. Host factors including age, sex, and comorbid conditions are key determinants of disease severity and progression. Aging itself is a prominent risk factor for severe disease and death from COVID-19. We hypothesize that age-related decline and dysregulation of immune function, i.e., immunosenescence and inflammaging play a major role in contributing to heightened vulnerability to severe COVID-19 outcomes in older adults. Much remains to be learned about the immune responses to SARS-CoV-2 infection. We need to begin partitioning all immunological outcome data by age to better understand disease heterogeneity and aging. Such knowledge is critical not only for understanding of COVID-19 pathogenesis but also for COVID-19 vaccine development.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.

              Studies have reminded that cardiovascular metabolic comorbidities made patients more susceptible to suffer 2019 novel corona virus (2019-nCoV) disease (COVID-19), and exacerbated the infection. The aim of this analysis is to determine the association of cardiovascular metabolic diseases with the development of COVID-19.
                Bookmark

                Author and article information

                Journal
                Hum Vaccin Immunother
                Hum Vaccin Immunother
                Human Vaccines & Immunotherapeutics
                Taylor & Francis
                2164-5515
                2164-554X
                9 October 2023
                2023
                9 October 2023
                : 19
                : 2
                : 2254539
                Affiliations
                [0001]Infectious Disease and Clinical Microbiology, Bursa Yuksek Ihtisas Training and Research Hospital; , Bursa, Turkey
                Author notes
                CONTACT Merve Sefa Sayar drmervesefasayar@ 123456yahoo.com Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi, Mimarsinan Mah; , Emniyet Cad., Yıldırım, Bursa 16310, Turkey.
                Author information
                https://orcid.org/0000-0002-0436-4122
                https://orcid.org/0000-0001-7988-0095
                https://orcid.org/0000-0001-6133-9604
                https://orcid.org/0000-0002-8856-7356
                Article
                2254539
                10.1080/21645515.2023.2254539
                10566376
                37814493
                59bfa77d-51b1-41f6-827b-61797fd081a4
                © 2023 The Author(s). Published with license by Taylor & Francis Group, LLC.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

                History
                Page count
                Figures: 0, Tables: 4, References: 26, Pages: 1
                Categories
                Research Article
                Coronavirus

                Molecular medicine
                covid-19 vaccines,health literacy,vaccine hesitancy
                Molecular medicine
                covid-19 vaccines, health literacy, vaccine hesitancy

                Comments

                Comment on this article